Identification of multiple genetic loci that regulate adenovirus gene therapy

Area of Science:

• Immunology
• Genetics
• Gene Therapy

Background:

• Adenovirus (Ad) gene therapy efficacy is significantly influenced by the host immune response, particularly the cytotoxic T-cell (CTL) response.
• Understanding the genetic basis of this immune response is crucial for optimizing Ad gene therapy strategies.

Purpose of the Study:

• To investigate the genetic factors influencing the immune response to AdLacZ gene therapy in recombinant inbred (RI) mice.
• To identify quantitative trait loci (QTLs) associated with beta-galactosidase (LacZ) expression, CTL response, and cytokine production.

Main Methods:

• Administration of AdLacZ to 20 strains of C57BL/6 x DBA/2 (BXD) RI mice.
• Analysis of liver LacZ expression and CTL response at multiple time points (days 7, 21, 30, 50).
• Measurement of serum cytokine levels (interferon gamma, tumor necrosis factor-alpha, interleukin-6) and QTL mapping.

Main Results:

• A significant strain-dependent variation in LacZ expression and CTL response was observed, with a strong correlation between them.
• Prolonged LacZ expression in some strains was associated with a defective Ad-specific CTL response.
• Distinct QTLs were identified for LacZ expression, cytotoxicity, and cytokine production across different chromosomes.

Conclusions:

• Host genetic polymorphisms play a critical role in determining the immune response and clearance of AdLacZ gene therapy vectors.
• Multiple genetic loci interact to regulate LacZ expression, CTL activity, and cytokine profiles, highlighting complex genetic control.
• These findings provide insights into the genetic architecture of Ad gene therapy responses and suggest potential targets for therapeutic modulation.